Latest medical news · page 264

FDA expands Skyrizi (risankizumab-rzaa) approval

Efficacy supplement (new or revised indication). injectable, injection. Sponsor: Abbvie Inc

FDA expands Xeljanz (tofacitinib citrate) approval

Efficacy supplement (new or revised indication). solution, oral. Sponsor: Pfizer

FDA expands Xeljanz (tofacitinib citrate) approval

Efficacy supplement (new or revised indication). tablet, oral. Sponsor: Pf Prism Cv

FDA expands Xeljanz Xr (tofacitinib citrate) approval

Efficacy supplement (new or revised indication). tablet, extended release, oral. Sponsor: Pfizer

FDA expands Sotyktu (deucravacitinib) approval

Efficacy supplement (new or revised indication). tablet, oral. Sponsor: Bristol

Notes from the Field: Exposures to Chemical Munitions During Commercial Fishing Operations - New Jersey, 2016-2023

This report describes exposures to chemical munitions during commercial fishing operations.

How to prepare for SOAP—even if you expect to match

NEJM This Week — March 5, 2026

This week, we explore a phase 3 trial of finerenone in type 1 diabetes and chronic kidney disease and guidance on timing of nonculprit-lesion PCI after STEMI. We cover an investigational therapy for Dravet syndrome and neoadjuvant treatment for high-risk intrahepatic cholangiocarcinoma. We review the effects of radiotherapy on normal tissue, a puzzling case of progressive neurologic decline after suspected foodborne illness, and Perspectives on private equity, the AHEAD model, and medical credit cards.

Alzheimer Disease: A Diagnostic Challenge

Dr. Centor discusses the diagnosis of Alzheimer disease with Dr. Gayatri Devi.

Diagnosis and Treatment of Chronic, Noninfectious Diarrhea

Chronic noninfectious diarrhea affects approximately 6% to 7% of adults in the US and significantly impairs quality of life. Author William Chey, MD, of the University of Michigan joins JAMA Deputy Editor Mary M. McDermott, MD, to discuss strategies for diagnosis and treatment of chronic, noninfectious diarrhea. Related Content: Chronic, Noninfectious Diarrhea

Secretary Kennedy Appoints Two Physicians to CDC's Advisory Committee on Immunization Practices

HHS and CDC today announced the appointment of two new members to the CDC ACIP.

Episode 248 -- February 2026 -- Part 2 AFP: American Family Physician

Long-term use of obesity management medications (1:30), cervical cancer screening (3:30), tinnitus (8:00), low back pain (10:30), impetigo (12:30), and computed tomography scans and lifetime cancer risk (15:50).

Butler-Williams Scholars Program 2026

Learn about the unique opportunities the Butler-Williams Scholars Program provides for junior faculty, researchers who are new to the field of aging, and postdoctoral fellows.

FDA expands Hernexeos (zongertinib) approval

Efficacy supplement (new or revised indication). tablet, oral. Sponsor: Boehringer Ingelheim

WHO Director-General visits Jordan to recognize strong collaboration on health system delivery, emergency relief and advancing mental health

The Director-General of the World Health Organization, Dr Tedros Adhanom Ghebreyesus, today concluded the first day of his two-day State visit to the Hashemite Kingdom of Jordan, underscoring the strong partnership between WHO and Jordan across the areas of universal health coverage (UHC), mental health and humanitarian health action.

NEJM This Week — February 26, 2026

This week, we explore a new standard of care for high-risk HER2-positive early breast cancer, long-acting therapy for people with HIV facing adherence challenges, a first-in-class trial of a p53 reactivator, and tecovirimat for mpox. We review group B streptococcal disease and a revealing case of prosthetic joint infection. Perspectives examine the role of folate therapy, Medicare drug-price negotiation, AI in medical education, and incidental findings.

Does This Patient Have Volume Overload? The Rational Clinical Examination

Accurate assessment of intravascular volume facilitates decisions about fluid management in patients with volume overload. Author Edmund A. Liles Jr, MD, of the University of Utah joins JAMA Associate Editor David Simel, MD, MHS, to discuss best evidence from physical exam findings including ultrasound, radiographs, and lab studies for determining volume overload in spontaneously breathing patients. Related Content: Does This Patient Have Volume Overload?

Statement on the Resignation of the CDC Principal Deputy Director

CDC announced Dr. Ralph Abraham stepped down as Principal Deputy Director, effective immediately.

FDA expands Dupixent (dupilumab) approval

Efficacy supplement (new or revised indication). injectable, injection. Sponsor: Regeneron Pharmaceuticals

FDA expands Venclexta (venetoclax) approval

Efficacy supplement (new or revised indication). tablet, oral. Sponsor: Abbvie

Candidates announced for AAFP president-elect, speaker, vice speaker, directors

NEJM This Week — February 19, 2026

This week, we highlight major advances in multiple myeloma, gene therapy for cystinosis, and experimental treatments for myotonic dystrophy. We review long-term outcomes of aortic-valve replacement, strategies for secondary stroke prevention, and a revealing diagnostic case of eosinophilic disease in an older adult. A Sounding Board explores FDA approval standards. Perspectives delve into tobacco cessation, influenza evolution, and the uncertainty patients and clinicians share when facing life-altering diagnoses.

Level 2 - Chikungunya in Suriname

There is an outbreak of chikungunya in Suriname. You can protect yourself by preventing mosquito bites.

Hyponatremia Correction: How Fast Is Too Fast?

Dr. Centor discusses hyponatremia correction rates with Dr. Dustin Mark.